Evaluating MTAP deletion and immune profile scores to identify unmet needs in solid tumors
Real-world data reveals MTAP deletions enrich for lower immune profile scores and worse outcomes
Co-occurrence likelihood (log odds ratio; x-axis) between MTAP deletion and IPS-high patients by MTAP deletion prevalence (y-axis) across solid tumor indications. Dot size indicates total count of MTAP deletion for each cancer type. Included samples required at least 40% tumor purity.
Lens Library
